Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Pharma Looks To Research, Drug Discovery To Make Rosy 2008 (India)

This article was originally published in PharmAsia News

Executive Summary

Many of India's drug makers see 2008 as a promising year for them and their decision to focus on discovering new drugs and doing research for multinationals. The chairman of Nicholas Piramal India says foreign pharmas finally have realized Indian companies have those capabilities. The realization came near the end of 2007, however, so the Indian industry depended on mergers and acquisitions strategies that largely failed to be fruitful. Indian pharmaceuticals did benefit in 2007 from increased sales in the domestic market. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC065926

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel